Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

SHA:600645 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	988.83	1,525	1,581	1,393	1,196	1,060
Trading Asset Securities	613.19	-	-	-	-	-
Cash & Short-Term Investments	1,602	1,525	1,581	1,393	1,196	1,060
Cash Growth	10.22%	-3.56%	13.48%	16.54%	12.76%	2.61%
Accounts Receivable	631.13	644.94	610.53	575.98	510.95	512.64
Other Receivables	11.13	11.6	18.09	28.41	16.58	28.24
Receivables	642.26	656.54	628.62	604.39	527.53	540.88
Inventory	236.91	232.19	247.9	248.09	226.96	222.4
Prepaid Expenses	0.67	0.51	2.38	6.48	2.98	-
Other Current Assets	43.64	42.08	48.36	57.64	77.08	91.51
Total Current Assets	2,526	2,456	2,508	2,310	2,030	1,915
Property, Plant & Equipment	652.82	688.71	705.33	765.54	766.09	733.46
Long-Term Investments	650.55	736.84	779.96	804.31	886.53	872.49
Goodwill	702.91	702.91	702.91	702.91	702.91	722.63
Other Intangible Assets	93.39	100.45	101.42	111.73	133.96	147.95
Long-Term Accounts Receivable	22.59	28.47	37.45	52	65.9	68.95
Long-Term Deferred Tax Assets	92.32	92.95	81.8	56.02	46.94	47.83
Long-Term Deferred Charges	162.24	165.22	159.98	148.88	141.13	130.63
Other Long-Term Assets	352.2	277.08	334	333.2	259.72	240.52
Total Assets	5,255	5,249	5,411	5,285	5,033	4,880
Accounts Payable	49.33	47.32	68.76	56.85	32.12	43.21
Accrued Expenses	152.96	170.15	146.96	134.91	132.33	120.21
Current Portion of Long-Term Debt	-	-	6.31	6.31	6.31	9.34
Current Portion of Leases	38.17	43.75	23.34	21.19	16.69	-
Current Income Taxes Payable	3.41	6.71	17.93	30.38	24.97	20.99
Current Unearned Revenue	1,132	1,134	1,137	1,112	1,078	1,024
Other Current Liabilities	82.13	85.4	81.29	109.64	105.56	82.41
Total Current Liabilities	1,458	1,487	1,482	1,471	1,396	1,300
Long-Term Debt	-	-	9.46	15.77	22.08	37.53
Long-Term Leases	54.21	80	88.37	97.9	37.11	11.6
Long-Term Unearned Revenue	9.31	9.56	10.02	10.92	11.08	13.64
Long-Term Deferred Tax Liabilities	11.98	12.95	23.15	34.87	34.7	14.41
Other Long-Term Liabilities	11.6	-	-	-	-	-
Total Liabilities	1,545	1,590	1,613	1,631	1,501	1,377
Common Stock	467.95	467.95	467.95	467.95	467.95	467.95
Additional Paid-In Capital	3,374	3,374	3,377	3,384	3,383	3,378
Retained Earnings	-136.15	-193.92	-294.27	-400.73	-513.71	-687.7
Treasury Stock	-200.03	-200.03	-	-	-	-
Comprehensive Income & Other	145.25	147.54	133.31	104.7	125.98	238.53
Total Common Equity	3,651	3,595	3,684	3,556	3,463	3,396
Minority Interest	58.48	63.98	114.55	97.85	69.31	106.03
Shareholders' Equity	3,709	3,659	3,799	3,654	3,533	3,502
Total Liabilities & Equity	5,255	5,249	5,411	5,285	5,033	4,880
Total Debt	92.38	123.75	127.48	141.18	82.2	58.48
Net Cash (Debt)	1,510	1,401	1,454	1,252	1,113	1,002
Net Cash Growth	13.97%	-3.61%	16.09%	12.46%	11.14%	11.58%
Net Cash Per Share	3.42	3.07	3.14	2.66	2.37	2.13
Filing Date Shares Outstanding	455.9	455.9	467.95	467.95	467.95	467.95
Total Common Shares Outstanding	455.9	455.9	467.95	467.95	467.95	467.95
Working Capital	1,067	968.93	1,027	838.53	634.56	615.09
Book Value Per Share	8.01	7.89	7.87	7.60	7.40	7.26
Tangible Book Value	2,854	2,792	2,880	2,741	2,627	2,526
Tangible Book Value Per Share	6.26	6.12	6.15	5.86	5.61	5.40
Land	3.52	3.54	3.49	3.43	3.14	3.21
Buildings	546.5	546.68	482.6	497.7	558.38	560.89
Machinery	708.67	700.82	690.88	653.02	623.86	583.77
Construction In Progress	11.94	10.54	18.98	23.23	20.5	8.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.